Bradley W Richmond
Affiliation: Vanderbilt University
- Histoplasmomas of uncommon sizeBradley W Richmond
Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
Chest 143:1795-8. 2013..The term "buckshot" calcification has been used to describe dozens of small (2-4 mm) calcified nodules, so it may be appropriate to label masses that exceed 3 cm as "cannonball" histoplasmoma...
- Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expressionBradley W Richmond
Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical School, Nashville, TN 37232 2363, USA
J Clin Immunol 33:446-55. 2013..It is unclear whether Th-17 cells in sarcoidosis are specific for mycobacterial antigens, or whether they have similar functionality to control Th-17 cells...
- Vitamin D, innate immunity, and sarcoidosis granulomatous inflammation: insights from mycobacterial researchBradley W Richmond
Department of Medicine, Vanderbilt University Medical School, Nashville, Tennessee 37232 2363, USA
Curr Opin Pulm Med 16:461-4. 2010..Here, we briefly review evidence that mycobacterial antigens are involved in sarcoidosis pathogenesis, and explore how defects in innate immunity might contribute to the disease...
- Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosisKyra A Oswald-Richter
Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
J Immunol 190:5446-53. 2013..These findings implicate normalized CD4(+) T cell function as a potential therapeutic target for sarcoidosis resolution...
- Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled studyWonder P Drake
Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee2Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee
JAMA Dermatol 149:1040-9. 2013..This is the first randomized, placebo-controlled study to demonstrate that antimycobacterial therapy reduces lesion diameter and disease severity among patients with chronic cutaneous sarcoidosis...